Acetyl-DL-leucine improves gait variability in patients with cerebellar ataxia—a case series

Acetyl-DL-leucine is a modified amino acid that was observed to improve ataxic symptoms in patients with sporadic and hereditary forms of ataxia. Here, we investigated the effect of the treatment with Acetyl-DL-leucine on the walking stability of patients with cerebellar ataxia (10x SAOA, 2x MSA-C,...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cerebellum Ataxias
Autors principals: Schniepp, Roman, Strupp, Michael, Wuehr, Max, Jahn, Klaus, Dieterich, Marianne, Brandt, Thomas, Feil, Katharina
Format: Artigo
Idioma:Inglês
Publicat: BioMed Central 2016
Matèries:
Letter to the Editor
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4828858/
https://ncbi.nlm.nih.gov/pubmed/27073690
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40673-016-0046-2
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars